TRAM flap breast reconstruction for patients with advanced breast disease

Amir B. Behnam, Doan Nguyen, Steven Lawrence Moran, Joseph M. Serletti, Robert X. Murphy, James W. May, Peter Cordeiro, Kenneth Marshall

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Transverse rectus abdominis musculocutaneous (TRAM) breast reconstruction in patients with advanced breast cancer is controversial. Management of these patients is often complex and consists of surgical extirpation, postoperative radiation, chemotherapy, and in some cases bone marrow transplantation. Few studies have attempted to examine patient long-term survival and overall satisfaction with the surgical procedure. This study examines one center's experience with patients undergoing breast reconstruction for stage III and stage IV breast carcinoma. A retrospective review was performed of all patients undergoing TRAM reconstruction with stage III or IV breast cancer. Surviving patients and family members were contacted for follow-up. Patients were asked to grade their satisfaction with the reconstructive procedure on a 5-point scale (5 points, extremely satisfied; 1 point, extremely dissatisfied). Postoperative complications and time to return to work were also recorded. During a 10-year period (1991-2000) 21 women underwent TRAM reconstruction for advanced breast cancer. Twenty patients had stage III disease and I patient had stage IV disease. Mean patient age was 49 years, A total of 26 TRAM flaps were performed; 5 patients had bilateral procedures. Of the 26 TRAM flaps, 17 were immediate and 9 were delayed, and 20 were free and 6 were pedicled. Follow-up averaged 6.5 years (range, 2-10 years). Postoperative complications occurred in 7 patients and included fat necrosis (N = 3), hematoma (N = 2), cellulitis (N = 1), delayed donor site healing (N = 2), and seroma (N = 1). There were no flap losses. Patients were able to return to normal activities or work at an average of 10.6 weeks. Eleven patients developed recurrent disease. Nine patients (43%) succumbed to their disease during the follow-up period. In these patients the average interval between TRAM reconstruction and death was 3.7 years (range, 1-6.5 years). Eleven patients or surviving family members participated in the patient satisfaction survey. The average satisfaction grade was 4.6 points. All patients would repeat the TRAM reconstruction again. Patients with advanced breast cancer can be considered appropriate candidates for TRAM reconstruction. The results of this study indicate that patients with advanced breast cancer do not have an increased rate of postoperative complications, and they recover within a reasonable time from their surgical procedure despite adjuvant radiation and chemotherapy. Furthermore, the majority of patients are satisfied with their reconstructed breast and postoperative course, and would choose this reconstructive option again.

Original languageEnglish (US)
Pages (from-to)567-571
Number of pages5
JournalAnnals of Plastic Surgery
Volume50
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Rectus Abdominis
Breast Diseases
Myocutaneous Flap
Mammaplasty
Breast Neoplasms
Radiation
Fat Necrosis

ASJC Scopus subject areas

  • Surgery

Cite this

Behnam, A. B., Nguyen, D., Moran, S. L., Serletti, J. M., Murphy, R. X., May, J. W., ... Marshall, K. (2003). TRAM flap breast reconstruction for patients with advanced breast disease. Annals of Plastic Surgery, 50(6), 567-571. https://doi.org/10.1097/01.SAP.0000069075.27321.BC

TRAM flap breast reconstruction for patients with advanced breast disease. / Behnam, Amir B.; Nguyen, Doan; Moran, Steven Lawrence; Serletti, Joseph M.; Murphy, Robert X.; May, James W.; Cordeiro, Peter; Marshall, Kenneth.

In: Annals of Plastic Surgery, Vol. 50, No. 6, 01.06.2003, p. 567-571.

Research output: Contribution to journalArticle

Behnam, AB, Nguyen, D, Moran, SL, Serletti, JM, Murphy, RX, May, JW, Cordeiro, P & Marshall, K 2003, 'TRAM flap breast reconstruction for patients with advanced breast disease', Annals of Plastic Surgery, vol. 50, no. 6, pp. 567-571. https://doi.org/10.1097/01.SAP.0000069075.27321.BC
Behnam, Amir B. ; Nguyen, Doan ; Moran, Steven Lawrence ; Serletti, Joseph M. ; Murphy, Robert X. ; May, James W. ; Cordeiro, Peter ; Marshall, Kenneth. / TRAM flap breast reconstruction for patients with advanced breast disease. In: Annals of Plastic Surgery. 2003 ; Vol. 50, No. 6. pp. 567-571.
@article{3193f01ab4414b918bac08d5a2472d57,
title = "TRAM flap breast reconstruction for patients with advanced breast disease",
abstract = "Transverse rectus abdominis musculocutaneous (TRAM) breast reconstruction in patients with advanced breast cancer is controversial. Management of these patients is often complex and consists of surgical extirpation, postoperative radiation, chemotherapy, and in some cases bone marrow transplantation. Few studies have attempted to examine patient long-term survival and overall satisfaction with the surgical procedure. This study examines one center's experience with patients undergoing breast reconstruction for stage III and stage IV breast carcinoma. A retrospective review was performed of all patients undergoing TRAM reconstruction with stage III or IV breast cancer. Surviving patients and family members were contacted for follow-up. Patients were asked to grade their satisfaction with the reconstructive procedure on a 5-point scale (5 points, extremely satisfied; 1 point, extremely dissatisfied). Postoperative complications and time to return to work were also recorded. During a 10-year period (1991-2000) 21 women underwent TRAM reconstruction for advanced breast cancer. Twenty patients had stage III disease and I patient had stage IV disease. Mean patient age was 49 years, A total of 26 TRAM flaps were performed; 5 patients had bilateral procedures. Of the 26 TRAM flaps, 17 were immediate and 9 were delayed, and 20 were free and 6 were pedicled. Follow-up averaged 6.5 years (range, 2-10 years). Postoperative complications occurred in 7 patients and included fat necrosis (N = 3), hematoma (N = 2), cellulitis (N = 1), delayed donor site healing (N = 2), and seroma (N = 1). There were no flap losses. Patients were able to return to normal activities or work at an average of 10.6 weeks. Eleven patients developed recurrent disease. Nine patients (43{\%}) succumbed to their disease during the follow-up period. In these patients the average interval between TRAM reconstruction and death was 3.7 years (range, 1-6.5 years). Eleven patients or surviving family members participated in the patient satisfaction survey. The average satisfaction grade was 4.6 points. All patients would repeat the TRAM reconstruction again. Patients with advanced breast cancer can be considered appropriate candidates for TRAM reconstruction. The results of this study indicate that patients with advanced breast cancer do not have an increased rate of postoperative complications, and they recover within a reasonable time from their surgical procedure despite adjuvant radiation and chemotherapy. Furthermore, the majority of patients are satisfied with their reconstructed breast and postoperative course, and would choose this reconstructive option again.",
author = "Behnam, {Amir B.} and Doan Nguyen and Moran, {Steven Lawrence} and Serletti, {Joseph M.} and Murphy, {Robert X.} and May, {James W.} and Peter Cordeiro and Kenneth Marshall",
year = "2003",
month = "6",
day = "1",
doi = "10.1097/01.SAP.0000069075.27321.BC",
language = "English (US)",
volume = "50",
pages = "567--571",
journal = "Annals of Plastic Surgery",
issn = "0148-7043",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - TRAM flap breast reconstruction for patients with advanced breast disease

AU - Behnam, Amir B.

AU - Nguyen, Doan

AU - Moran, Steven Lawrence

AU - Serletti, Joseph M.

AU - Murphy, Robert X.

AU - May, James W.

AU - Cordeiro, Peter

AU - Marshall, Kenneth

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Transverse rectus abdominis musculocutaneous (TRAM) breast reconstruction in patients with advanced breast cancer is controversial. Management of these patients is often complex and consists of surgical extirpation, postoperative radiation, chemotherapy, and in some cases bone marrow transplantation. Few studies have attempted to examine patient long-term survival and overall satisfaction with the surgical procedure. This study examines one center's experience with patients undergoing breast reconstruction for stage III and stage IV breast carcinoma. A retrospective review was performed of all patients undergoing TRAM reconstruction with stage III or IV breast cancer. Surviving patients and family members were contacted for follow-up. Patients were asked to grade their satisfaction with the reconstructive procedure on a 5-point scale (5 points, extremely satisfied; 1 point, extremely dissatisfied). Postoperative complications and time to return to work were also recorded. During a 10-year period (1991-2000) 21 women underwent TRAM reconstruction for advanced breast cancer. Twenty patients had stage III disease and I patient had stage IV disease. Mean patient age was 49 years, A total of 26 TRAM flaps were performed; 5 patients had bilateral procedures. Of the 26 TRAM flaps, 17 were immediate and 9 were delayed, and 20 were free and 6 were pedicled. Follow-up averaged 6.5 years (range, 2-10 years). Postoperative complications occurred in 7 patients and included fat necrosis (N = 3), hematoma (N = 2), cellulitis (N = 1), delayed donor site healing (N = 2), and seroma (N = 1). There were no flap losses. Patients were able to return to normal activities or work at an average of 10.6 weeks. Eleven patients developed recurrent disease. Nine patients (43%) succumbed to their disease during the follow-up period. In these patients the average interval between TRAM reconstruction and death was 3.7 years (range, 1-6.5 years). Eleven patients or surviving family members participated in the patient satisfaction survey. The average satisfaction grade was 4.6 points. All patients would repeat the TRAM reconstruction again. Patients with advanced breast cancer can be considered appropriate candidates for TRAM reconstruction. The results of this study indicate that patients with advanced breast cancer do not have an increased rate of postoperative complications, and they recover within a reasonable time from their surgical procedure despite adjuvant radiation and chemotherapy. Furthermore, the majority of patients are satisfied with their reconstructed breast and postoperative course, and would choose this reconstructive option again.

AB - Transverse rectus abdominis musculocutaneous (TRAM) breast reconstruction in patients with advanced breast cancer is controversial. Management of these patients is often complex and consists of surgical extirpation, postoperative radiation, chemotherapy, and in some cases bone marrow transplantation. Few studies have attempted to examine patient long-term survival and overall satisfaction with the surgical procedure. This study examines one center's experience with patients undergoing breast reconstruction for stage III and stage IV breast carcinoma. A retrospective review was performed of all patients undergoing TRAM reconstruction with stage III or IV breast cancer. Surviving patients and family members were contacted for follow-up. Patients were asked to grade their satisfaction with the reconstructive procedure on a 5-point scale (5 points, extremely satisfied; 1 point, extremely dissatisfied). Postoperative complications and time to return to work were also recorded. During a 10-year period (1991-2000) 21 women underwent TRAM reconstruction for advanced breast cancer. Twenty patients had stage III disease and I patient had stage IV disease. Mean patient age was 49 years, A total of 26 TRAM flaps were performed; 5 patients had bilateral procedures. Of the 26 TRAM flaps, 17 were immediate and 9 were delayed, and 20 were free and 6 were pedicled. Follow-up averaged 6.5 years (range, 2-10 years). Postoperative complications occurred in 7 patients and included fat necrosis (N = 3), hematoma (N = 2), cellulitis (N = 1), delayed donor site healing (N = 2), and seroma (N = 1). There were no flap losses. Patients were able to return to normal activities or work at an average of 10.6 weeks. Eleven patients developed recurrent disease. Nine patients (43%) succumbed to their disease during the follow-up period. In these patients the average interval between TRAM reconstruction and death was 3.7 years (range, 1-6.5 years). Eleven patients or surviving family members participated in the patient satisfaction survey. The average satisfaction grade was 4.6 points. All patients would repeat the TRAM reconstruction again. Patients with advanced breast cancer can be considered appropriate candidates for TRAM reconstruction. The results of this study indicate that patients with advanced breast cancer do not have an increased rate of postoperative complications, and they recover within a reasonable time from their surgical procedure despite adjuvant radiation and chemotherapy. Furthermore, the majority of patients are satisfied with their reconstructed breast and postoperative course, and would choose this reconstructive option again.

UR - http://www.scopus.com/inward/record.url?scp=0037945372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037945372&partnerID=8YFLogxK

U2 - 10.1097/01.SAP.0000069075.27321.BC

DO - 10.1097/01.SAP.0000069075.27321.BC

M3 - Article

C2 - 12783000

AN - SCOPUS:0037945372

VL - 50

SP - 567

EP - 571

JO - Annals of Plastic Surgery

JF - Annals of Plastic Surgery

SN - 0148-7043

IS - 6

ER -